UBS O'Connor’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,000
| Closed | -$63.2K | – | 384 |
|
|
2024
Q4 | $63.2K | Buy |
+5,000
| New | +$63.2K | ﹤0.01% | 319 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 509 |
|
|
2024
Q2 | – | Sell |
-9,136
| Closed | -$656K | – | 535 |
|
|
2024
Q1 | $656K | Buy |
9,136
+1,400
| +18% | +$101K | 0.02% | 310 |
|
|
2023
Q4 | $1.54M | Sell |
7,736
-3,991
| -34% | -$793K | 0.05% | 214 |
|
|
2023
Q3 | $1.56M | Sell |
11,727
-375
| -3% | -$49.9K | 0.03% | 273 |
|
|
2023
Q2 | $1.81M | Buy |
12,102
+596
| +5% | +$89.2K | 0.04% | 314 |
|
|
2023
Q1 | $1.69M | Buy |
+11,506
| New | +$1.69M | 0.04% | 349 |
|
|
2022
Q4 | – | Sell |
-8,727
| Closed | -$1.68M | – | 244 |
|
|
2022
Q3 | $1.68M | Sell |
8,727
-1,117
| -11% | -$215K | 0.02% | 662 |
|
|
2022
Q2 | $1.44M | Buy |
+9,844
| New | +$1.44M | 0.01% | 711 |
|
|
2020
Q2 | – | Sell |
-1,250
| Closed | -$213K | – | 344 |
|
|
2020
Q1 | $213K | Buy |
+1,250
| New | +$213K | ﹤0.01% | 253 |
|